These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16381997)

  • 1. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism.
    Kobayashi K; Imanishi Y; Miyauchi A; Onoda N; Kawata T; Tahara H; Goto H; Miki T; Ishimura E; Sugimoto T; Ishikawa T; Inaba M; Nishizawa Y
    Eur J Endocrinol; 2006 Jan; 154(1):93-9. PubMed ID: 16381997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23, metabolic risk factors, and blood pressure in patients with primary hyperparathyroidism undergoing parathyroid adenomectomy.
    Nilsson IL; Norenstedt S; Granath F; Zedenius J; Pernow Y; Larsson TE
    Surgery; 2016 Jan; 159(1):211-7. PubMed ID: 26435425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?
    Witteveen JE; van Lierop AH; Papapoulos SE; Hamdy NA
    Eur J Endocrinol; 2012 Jan; 166(1):55-60. PubMed ID: 21984611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism.
    Yamashita H; Yamashita T; Miyamoto M; Shigematsu T; Kazama JJ; Shimada T; Yamazaki Y; Fukumoto S; Fukagaw M; Noguchi S
    Eur J Endocrinol; 2004 Jul; 151(1):55-60. PubMed ID: 15248822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
    Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.
    Kawata T; Imanishi Y; Kobayashi K; Miki T; Arnold A; Inaba M; Nishizawa Y
    J Am Soc Nephrol; 2007 Oct; 18(10):2683-8. PubMed ID: 17855636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?
    Carsello CB; Yen TW; Wang TS
    Surgery; 2012 Oct; 152(4):575-81; discussion 581-3. PubMed ID: 23021134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
    Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ
    PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
    Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
    Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and management of patients with primary hyperparathyroidism in Italy.
    Saponaro F; Cetani F; Repaci A; Pagotto U; Cipriani C; Pepe J; Minisola S; Cipri C; Vescini F; Scillitani A; Salcuni A; Palmieri S; Eller-Vainicher C; Chiodini I; Madeo B; Kara E; Castellano E; Borretta G; Gianotti L; Romanelli F; Camozzi V; Faggiano A; Corbetta S; Cianferotti L; Brandi ML; De Feo ML; Palermo A; Vezzoli G; Maino F; Scalese M; Marcocci C
    J Endocrinol Invest; 2018 Nov; 41(11):1339-1348. PubMed ID: 29616419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.
    Tebben PJ; Singh RJ; Clarke BL; Kumar R
    Mayo Clin Proc; 2004 Dec; 79(12):1508-13. PubMed ID: 15595334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
    Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
    Boudou P; Ibrahim F; Cormier C; Sarfati E; Souberbielle JC
    J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
    Imanishi Y; Kobayashi K; Kawata T; Inaba M; Nishizawa Y
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S32-7. PubMed ID: 17976083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy.
    Mazeh H; Chen H; Leverson G; Sippel RS
    Ann Surg; 2013 Jan; 257(1):138-41. PubMed ID: 22801087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
    Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
    Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.